JARRED P REED

Allopathic & Osteopathic Physicians|Internal Medicine LOS ANGELES, CA NPI 1013250869

General Payments — all program years on this page

$4,888.27

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 82
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,917.02 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $2,625.005
Food and Beverage $275.6211
Education $16.401

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $726.1614
2019 $504.0322
2020 $233.088
2021 $35.992
2022 $121.625
2023 $350.3714
2024 $2,917.0217

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093912538 Alexion Pharmaceuticals, Inc. $23.15 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094032499 Alexion Pharmaceuticals, Inc. $26.47 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1094044982 Alexion Pharmaceuticals, Inc. $26.63 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104199125 AstraZeneca Pharmaceuticals LP $525.00 10/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104268919 AstraZeneca Pharmaceuticals LP $15.06 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104309776 AstraZeneca Pharmaceuticals LP $525.00 10/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104472700 AstraZeneca Pharmaceuticals LP $525.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105491485 AstraZeneca Pharmaceuticals LP $525.00 10/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105741726 AstraZeneca Pharmaceuticals LP $525.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105931342 ABBVIE INC. $22.72 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114145025 Regeneron Healthcare Solutions, Inc. $38.00 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117165020 Mirati Therapeutics, Inc. $23.61 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133027136 Genentech USA, Inc. $30.88 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133766355 Gilead Sciences, Inc. $30.57 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133766357 Gilead Sciences, Inc. $13.36 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141203521 Incyte Corporation $25.17 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144965885 Takeda Pharmaceuticals U.S.A., Inc. $16.40 03/26/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.